Regulatory Scientific Advice on Non-Inferiority Drug Trials

The active-controlled trial with a non-inferiority design has gained popularity in recent years. However, non-inferiority trials present some methodological challenges, especially in determining the non-inferiority margin. Regulatory guidelines provide some general statements on how a non-inferiorit...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wangge, Grace, Putzeist, Michelle, Knol, Mirjam J., Klungel, Olaf H., Gispen-De Wied, Christine C., de Boer, Antonius, Hoes, Arno W., Leufkens, Hubert G., Mantel-Teeuwisse, Aukje K.
Format:	Artigo
Language:	Inglês
Published:	Public Library of Science 2013
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3764030/ https://ncbi.nlm.nih.gov/pubmed/24040346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0074818
Tags:	Add Tag No Tags, Be the first to tag this record!

Regulatory Scientific Advice on Non-Inferiority Drug Trials

Similar Items